The Role of the Transcription Factor E2F1 in Hepatocellular Carcinoma

E-ISSN： 1875-5704|14|2|272-281

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.14, Iss.2, 2017-02, pp. : 272-281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypoxia-inducible Factor-1alpha: Molecular-targeted Therapy for Hepatocellular Carcinoma

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 9, 2013-07 ,pp. : 1295-1304

Bentham Science Publishers

Access to resources Recommend Favorite

Glioblastoma Multiforme Formation and EMT: Role of FoxM1 Transcription Factor

Current Pharmaceutical Design, Vol. 21, Iss. 10, 2015-03 ,pp. : 1268-1271

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of IRF1 and IRF2 Transcription Factors in Leukaemogenesis

Current Gene Therapy, Vol. 6, Iss. 5, 2006-10 ,pp. : 543-550

Bentham Science Publishers

Access to resources Recommend Favorite

The Transcription Factor ETS-1: Its Role in Tumour Development and Strategies for its Inhibition

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 11, 2008-10 ,pp. : 1095-1105

Bentham Science Publishers

Access to resources Recommend Favorite

Chebulagic Acid Synergizes the Cytotoxicity of Doxorubicin in Human Hepatocellular Carcinoma Through COX-2 Dependant Modulation of MDR-1

Medicinal Chemistry, Vol. 7, Iss. 5, 2011-09 ,pp. : 432-442

Bentham Science Publishers

Access to resources Recommend Favorite